The present disclosure relates to a naltrexone sustained release microparticle delivery system for the treatment of diseases ameliorated by naltrexone. Such injectable microparticle delivery systems comprise naltrexone encapsulated in biodegradable microparticles administered in a pharmaceutically acceptable vehicle.
展开▼